Funding innovative researchers studying the biology and mechanisms of disease which has the long term goal of changing clinical practice for treating disease.
Professor Lorenzetti studies the neurobiology of substance use and addiction to identify those most vulnerable to brain and mental health harms, and develops brain-based interventions to reduce addiction-related harm. Learn more about her research 👇.
@vale_addiction@HBMRC_ACU
What a wonderful evening with such passionate researchers. Congratulations to our new Fellows — @nir_eynon, Katie Ayers, Bingyang Shi, @Chantal_Donovan and @RhiannonWerder (and Alice Kane). Special recognition to Prof Mark Cooper for outstanding service to the Foundation.
Congrats to A/Prof Katie Ayers, #MCRI and @nir_eynon, @ARMI_Labs, on receiving 2026 Rebecca Cooper Fellowships. This outstanding achievement recognises them as leaders in their respective fields of Medical Research, whose work exemplifies excellence and innovation.👏👏👏
A/Prof Reed aims to use genomics to transform the diagnosis and treatment of autoimmune disease and has a particular focus on Sjogren’s syndrome. @WestmeadInst Find out more about her research here 👇
A/Prof Susanna Park's translational neurology research program is develop clinically relevant biomarkers to enable earlier diagnosis and targeted therapeutic interventions for patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN). @BrainMind_Usyd Find out more 👇
Big congrats to Maria Di Biase 👏👏, our Al & Val Rosenstrauss Fellow, on being awarded the #MetcalfPrizes by the National Stem Cell Foundation of Australia in recognition of her leadership in stem cell research. You can read more about Maria’s work at https://t.co/pZKQvVve2z
Prof Lazarou’s ground-breaking research aims to develop therapeutics that target mitochondrial dysfunction in diseases ranging from Parkinson’s Disease (PD) and beyond. @LazarouLab Find out more about his research here👇
Gang Liu aims to identify new therapies for Idiopathic Lung Fibrosis (IPF), a chronic and progressive disease which currently has a poor prognosis for those suffering the disease. Find out more about his research 👇
Dr Maria Di Biase @UniMelb discusses her novel research which aims to pioneer personalised treatment interventions for individuals with schizophrenia by incorporating their unique genetic, molecular, and functional illness profiles. 👇
Congratulations to A/Prof Susanna Park @BrainMind_Usyd on being awarded the 2025 Rebecca Cooper Fellowship! With $1.5 mil in support, A/Prof Park will propel her groundbreaking research to understand how chemotherapy produces nerve damage, to improve diagnosis and treatment.
@JiaoJiaoLi_Syd is a biomedical engineer working in tissue engineering and regenerative medicine to deliver personalised therapies for joint diseases. Hear more about her research 👇
Very proud of our Al & Val Rosenstrauss Fellow, A/Prof Miguel Renteria, who has published a landmark paper in Nature Genetics which provides an insight into the intricate relationship between our genetic makeup and brain health.
@SCMGroup_SCOF uses 3D retinal organoids to investigate therapeutic avenues for treating blindness caused by degeneration of the retina. Hear more about her research 👇